Kugba-Ajagbe | Amini | p-value | ||
---|---|---|---|---|
No of eligible persons surveyed | ||||
Female | 32 | 23 | ||
Male | 29 | 18 | ||
Total | 61 | 41 | ||
No. of persons treated (%) | ||||
Female | 17 (68.0) | 14 (51.9) | ||
Male | 8 (32.0) | 13 (48.1) | ||
Total coverage | 25 (41.0) | 27 (65.9) | 0.024* | |
Anopheles sp. | ||||
Indoor density | 14–13 days before MDA | 1.97 | 0.90 | |
2–3 days post-MDA | 1.70 (p = 0.446) | 0.33 (p = 0.005)† | ||
13–14 days post-MDA | 1.93 (p = 0.926) | 0.97 (p = 0.789) | ||
Outdoor density | 14–13 days before MDA | 1.00 | 0.17 | |
2–3 days post-MDA | 0.83 (p = 0.763) | 1.00 (0.068) | ||
13–14 days post-MDA | 0.33 (p = 0.157) | 0.00 | ||
Indoor parity rate | 14–13 days before MDA | 96.61 | 92.59 | |
2–3 days post-MDA | 45.10 (p < 0.001)† | 40.00 (p = 0.002)† | ||
13–14 days post-MDA | 67.24 (p < 0.001)† | 93.10 (p = 0.667) | ||
Outdoor parity rate | 14–13 days before MDA | 83.33 | 100.00 | |
2–3 days post-MDA | 80.00 (p = 0.727) | 50.00 (p = 0.600) | ||
13–14 days post-MDA | 0.00 (p = 0.107) | – | ||
Culex sp. | ||||
Indoor density | 14–13 days before MDA | 0.13 | 0.00 | |
2–3 days post-MDA | 0.07 (p = 0.414) | 0.13 | ||
13–14 days post-MDA | 0.23 (p = 0.366) | 0.27 | ||
Outdoor density | 14–13 days before MDA | 1.50 | 4.17 | |
2–3 days post-MDA | 5.33 (p < 0.001)† | 1.75 (p = 0.036)† | ||
13–14 days post-MDA | 1.50 (p = 1.000) | 0.50 (p = 0.001)† | ||
Indoor parity rate | 14–13 days before MDA | 100.00 | – | |
2–3 days post-MDA | 100.00 | 100.00 | ||
13–14 days post-MDA | 100.00 | 87.50 | ||
Outdoor parity rate | 14–13 days before MDA | 88.89 | 64.00 | |
2–3 days post-MDA | 96.88 (p = 0.395) | 100.00 (p = 0.073) | ||
13–14 days post-MDA | 88.89 (p = 0.765) | 100.00 (p = 0.436) |